University of Maryland School of Pharmacy. Annual Report 2004-2005

Item Type Annual Report

Publication Date 2005

Keywords University of Maryland, Baltimore. School of Pharmacy--Annual Reports

Publisher University of Maryland, Baltimore. School of Pharmacy

Download date 26/09/2021 23:18:02

Item License https://creativecommons.org/licenses/by-nc-nd/4.0/

Link to Item http://hdl.handle.net/10713/249 focus

UNIVERSITY OF MARYLAND | SCHOOL OF PHARMACY

ANNUAL REPORT 2004-2005 CONTENTS LEADERSHIP

David A. Knapp, PhD Dean

William J. Cooper, MBA Associate Dean for Administration and Finance 2 DEAN’S MESSAGE Jill Morgan, PharmD Associate Dean for Student Affairs 3 Magaly Rodriguez de Bittner, PharmD STRATEGIC PLAN Associate Dean for Academic Affairs

Angela Wilks, PhD 4 Associate Dean for Research and Graduate Education ACADEMIC PROGRAMS

Natalie D. Eddington, PhD DOCTOR OF PHARMACY PROGRAM Chair, Department of Pharmaceutical Sciences PHARMACEUTICAL HEALTH SERVICES RESEARCH GRADUATE PROGRAM

Robert J. Michocki, PharmD PHARMACEUTICAL SCIENCES GRADUATE PROGRAM Chair, Department of Pharmacy Practice and Science

C. Daniel Mullins, PhD 10 Chair, Department of Pharmaceutical Health Services Research ACADEMIC TRAINING

POSTDOCTORAL TRAINING

RESIDENCY AND FELLOWSHIP TRAINING CENTERS 14 GRANTS AND AWARDS

Center on Drugs and Public Policy Francis B. Palumbo, PhD, JD, Director 21 SCHOOL OF PHARMACY CENTERS Computer-Aided Drug Design Center Alexander D. MacKerell, Jr., PhD, Director 22 Drug Information Center FINANCIALS Rachel A. Bongiorno, PharmD, Director

Maryland Poison Center 24 Bruce D. Anderson, PharmD, Director DEVELOPMENT

Center for Nanomedicine and Cellular Delivery Hamid Ghandehari, PhD, Director

Office of Substance Abuse Studies Anthony C. Tommasello, PhD, Director

The Peter Lamy Center on Drug Therapy and Aging Bruce C. Stuart, PhD, Director

Pharmaceutical Research Computing Van Doren Hsu, PharmD, Director S C

DEAN’S MESSAGE STRATEGIC PLAN H O

2005-2008 O L O F P H A R M A

Maryland is a comprehensive School of Pharmacy. By that, I mean it aims to not only C MISSION Y educate excellent pharmacists, but also seek excellence in research, clinical practice, and We enhance health through innovative pharmaceutical 4 service to the profession and society. We cannot, however, do everything. Although we 5 F

are among the largest schools of pharmacy in the nation, we are one of the smaller education, research, practice, and public service. Y 0 5

schools on the University of Maryland, Baltimore campus. To achieve excellence within A N

VISION 2010 N

our comprehensive mission, we must focus on what we want to do. U A

We lead the way in advancing the profession of pharmacy. L R

• In the PharmD program, we focus on teaching our students how to E P learn and how to choose the best career path from the richness that In our innovative educational, research, and practice settings, students gain the O R the profession offers. knowledge and skill to excel in a variety of pharmaceutical careers. Employing a spirit of T discovery fostered during the course of their studies, our graduates are leaders wherever • In research, we focus on drug discovery, drug development, and they practice, conduct research, or teach. They are essential contributors in the dynamic medication use, seeking to complement the strengths of other health care arena meeting the need for pharmacists within the state of Maryland and campus units. beyond. • In clinical practice, we focus on community practice and on specialty As a top-five research School, we apply an integrative understanding of drug discovery, areas where significant opportunities for collaboration exist. development, and utilization in conducting groundbreaking and translational research. The outcomes from this research make a major impact on improving the quality of • In public service, our focus responds to the needs of our community, people’s lives. our state, and the world around us. We are a formidable influence in shaping drug policy and pharmaceutical practice. The insatiable list of things we might do, coupled with the finite resources we have to Our community service programs bring education and care to people in Baltimore City offer, forces us to focus. Strategic planning provides the mechanism through which we and throughout the state. These endeavors, coupled with our national and international make our choices. collaborations, improve the effectiveness of pharmaceutical care throughout the world. Our faculty, staff, and students create and sustain a welcoming and supportive For better than a year, a special Task Force on the Future of the School of Pharmacy, environment where people develop professionally and use their knowledge and talents composed of members of our faculty and staff, worked to develop our Strategic Plan for to realize this vision. 2005-2008. The plan encompasses a vision for the School that places us in the midst of dynamic changes that are taking place in health care, biomedical research, and health STRATEGIC INITIATIVES professions education. 1 To retain our position as a leader among schools of pharmacy, we will once again Educate the highest caliber pharmacists and pharmaceutical scientists rethink our curriculum, incorporating educational technology to change the ways that we to meet societal needs and market demands. help students learn. In research, we will more fully exploit our contributions to cross- 2 disciplinary, translational, and health services research. And, finally, in order to best prepare Define the future role of pharmacists in health care. our students for the profession of tomorrow, our faculty members will continue to be engaged clinically in the practice of today. 3 Advance the viability and impact of research and scholarship throughout the School. Here then, is the product of our focus in academic year 2005—our Strategic Plan for the years to come. 4 Enhance relationships with external stakeholders.

5 Create a culture of trust, appreciation, and continuous learning within the School.

David A. Knapp, PhD Dean SCHOOL OF PHARMACY 7 FY05 ANNUAL REPORT RPh, PhD, who , had many accomplish- was named associate dean for student affairs , harmD

STUDENT GOVERNMENT ASSOCIATION L on June 1, 2005. She succeeded Robert Beardsley JILL MORGAN, P stepped down after 17 years of dedicated service to resume his full- time faculty position in the Department of Pharmaceutical Health Services Research. L The ments during the 2004-05 year. They were successful in arranging ments during the 2004-05 year. 42 students to meet with legislators, helped organize the School’s during Showcase in Annapolis participation in the UMB Health Care the 2005 legislative session, established online elections, devel- oped an interactive suggestion box, and instituted a new tradition: The Spring Formal. U.S.News & World Report % % % 221 and 85th % 1 4 3 15 % 26 % 52 % 120 3.5 # 65 65/45 19-40 25.3 Asian Ethnicity aucasian Hispanic C Age Range Mean GPA OGRAM Average Age Average International R CADEMIC PROGRAMS CADEMIC P A Native American African-American Students Enrolled Percent Female/Male ional ARMACY s is Percent with Baccalaureate es m

H f o • l P Mean PCAT ( # and percentile) Mean PCAT r e p a

• d

e

n r

o s

i

h t

CTOR OF

The 2004-05 year was rewarding for the School of Pharmacy. rewarding for the School of Pharmacy. The 2004-05 year was enrollment to help of space, the School maintained an increased Despite a shortage i

a p

O

focus c

ranked the School eighth in the nation for the quality of our Doctor of Pharmacy educa- in the nation for the quality of our ranked the School eighth This valida- in the country. ranking as one of the very best schools tion, maintaining our from throughout the helps us attract top-notch students tion of Maryland’s stature nation. an applicant pool of 1,463, an increase shortage in Maryland. From with the pharmacist 145 were offered the opportunity to interview, 236 had year, of 758 over the previous enrolled. admission, and 120 • D Meet the Incoming Class of 2008 Meet u

s

d

c

e

i

•

e

y

n

t

c i l e

a u • q 6 SCHOOL OF PHARMACY 9 FY05 ANNUAL REPORT PhD candidate, received the University of Maryland, a , 4 3.75 50/50 1 3 Ethnicity Mean GPA “I decided to attend the University of Maryland Department of Pharmaceutical Jose (pictured left) is walking with PhD candidate Nour Obeidat. JOSE JOSUE HERNANDEZ Baltimore, Graduate School Enrichment Fellowship for the academic years 2004-05 Baltimore, Graduate School Enrichment Fellowship and 2005-06, and completed an internship at Pfizer Global Epidemiology in Barcelona, Spain, in spring 2005. His research focus area is pharmacoepidemiology of aging. His dissertation research is, “Disparities in Optimal Prescribing Between Elderly Residents With and Without Dementia.” Care Medicare Long-Term Health Services Research because of the diverse research opportunities within the department, and its reputation,” says Hernandez. Once he completes his doctoral degree, he plans to pursue an academic career at the University of Puerto Rico and to continue his research in the field of suboptimal prescribing among elderly subjects. He has a BSPharm from the University of Puerto Rico School of Pharmacy and an MPH in Epidemiology from its School of Public Health. Students Enrolled International, Asian Percent Female/Male

FOCUS ON RESEARCH rch • ea po s l i African-American, Non Hispanic e c r y

•

•

s s

With the widespread use of medications in society, the demand for individuals skilled the demand for individuals use of medications in society, With the widespread they of study, in the program. During their course 26 students are enrolled Currently, interest include the role of the federal and state Some areas of academic and research

e focus e

Meet the Students Who Enrolled in 2004 Meet

in the evaluation of pharmaceutical services and interventions has increased. To help has increased. To pharmaceutical services and interventions in the evaluation of Research graduate the Pharmaceutical Health Services meet this growing demand, 2004-05 year in a variety of to train strong researchers during the program continued important areas. skills needed to experience, and the decision-making practical are provided with theory, of pharmacy-related problems. address a wide range drug utilization, cost contain- third-party programs, governments in health care policy, of pharmaceutical services, role of health ment, medication compliance, provision into the medical care setting. practitioners, and diffusion of new technologies Pharmaceutical Health Services Research Graduate Program Graduate Services Research Health Pharmaceutical r

m

v

o

i

c

c

t e u o • 8 SCHOOL OF PHARMACY 11 FY05 ANNUAL REPORT , ellowship. PhD candidate with an area of PhD candidate with an , PhD candidate with a research focus area in area PhD candidate with a research focus , RAINES Y After completing her graduate work, Raines plans to After completing her graduate work, Raines Once Kitchens completes her graduate studies, she plans research in the cellular and biological chemistry pathway research in the cellular received the Meyerhoff Graduate Research F received the Meyerhoff Her dissertation research is, “Cell Signaling by Nitric Her dissertation research is, “Cell Protein Oxide Synthases: Examining Mitogen Activated Host Kinase Regulation and the Regulation of Innate Immunity.” “I chose obtain postdoctoral training in cancer biology. Sciences at to attend the Department of Pharmaceutical graduate the University of Maryland, Baltimore for my the ability to studies,” she says, “because of the faculty, collaborate in research endeavors, and its location.” KIMBERL L L KELLY KITCHENS KELLY biopharmaceutics and drug delivery technology, received the National Institute of General Medical Sciences Fellowship. of Poly Transport Her dissertation research is, “Transepithelial (Amidoamine) Dendrimers across the Intestinal Epithelium.” to pursue either a postdoctoral position in the field of tissue engineering/biomaterials or a career in regulatory affairs. “I decided to attend the University of Maryland Pharmaceutical Sciences program,” she says, “because of the diverse research opportunities within the department, the reputation, and the location.” became the new graduate ,

L PAUL SHAPIRO, PhD program director for the Department of Pharmaceutical Sciences on June 1, 2005. 36 % 26 % 16 % 11 % 11 % 19 3.30 63/37 7 5 3 2 2 Asian Ethnicity Hispanic Caucasian Mean GPA International African-American Students Enrolled Percent Female/Male

• impa ry ct e • v c o o c l s l

i a

d

b

•

The Department of Pharmaceutical Sciences graduate program continued to prepare Pharmaceutical Sciences graduate program The Department of of Pharmaceutical Sciences are and graduate students in the Department Faculty o

focus

r

Pharmaceutical Sciences Graduate Program Graduate Sciences Pharmaceutical currently With 72 students scientists during the 2004-05 year. independent, creative cellular and molecular biology, is rapidly expanding in the areas of enrolled, the program and and drug delivery, biopharmaceutics neuroscience and pharmacology, chemistry, sciences. clinical pharmaceutical Pharmacology Chemistry, and Biological Pathways: Cellular organized into Research Clinical and Biopharmaceutics and Drug Delivery Technology, and Neuroscience, is to foster individual The mission of each Research Pathway Pharmaceutical Sciences. and a graduate student education, which and collaborative research, faculty growth, the drug development process along with provides a strong, broad background in of the pharmaceutical sciences. intensive expertise in a focal research area h Meet the Students Who Enrolled in 2004 Meet

a c

t

r

i

a

o

e

n s e r • 10 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 13 - - is a second- and final-year postdoctoral , hD ech to seek training in pharmacoeconomic research. ech to seek training in pharmacoeconomic Mullins has provided me with exactly the type of postdoctoral training I Mullins has provided me with exactly the type . orking under the mentorship of C. Daniel Mullins, PhD, Akobundu is orking under the mentorship of C. Daniel Mullins, The Pharmaceutical Research and Manufacturers of America Foundation awarded The Pharmaceutical Research and Manufacturers of America Foundation W Akobundu plans to seek opportu Upon completion of her postdoctoral training, EBERECHUKWU AKOBUNDU, P ACADEMIC TRAINING ACADEMIC nities in an interdisciplinary academic environment. She is particularly interested in nities in an interdisciplinary academic environment. the specification and testing of statistical models used in the analysis of health economic data. “My long-term goal is to contribute to the methods of analyzing costs by way of expanding our statistical tool kit, improving our ability to rigorously test improve our confidence and decision makers’ model assumptions, and, ultimately, confidence in the results of our research on health outcomes and health services utilization,” she says. in Health Outcomes for her research, Akobundu the 2005 Postdoctoral Fellowship “The Application of the Probabilistic Reduction Approach to Health Econometric Model Specification and Testing.” fellow in the Department of Pharmaceutical Health Services Research. With a PhD in fellow in the Department of Pharmaceutical Akobundu came to the School of economics and a specialization in econometrics, Pharmacy from Virginia T cost data, the cost-effectiveness of conducting research on statistical models of and the pharmacologic treatment of tiotropium bromide in the veterans’ population, as it relates to treatment guide atrial fibrillation patients in the veterans’ population lines. “Dr career-oriented,” says Akobundu. sought: rigorous, disciplined, unselfish, and

• ment FOCUS ON RESEARCH t o en rs m h p ip o l •

c

e o

v

l e

l

Postdoctoral training is a preferred step on the path to a research career in the bio- is a preferred step on the path to a research Postdoctoral training faculty mentor with whom are recruited to the institution by the Postdoctoral fellows d a

focus •

b

Postdoctoral Training Training Postdoctoral of postdoctoral fellows is health services research. The number medical sciences and prior to the initiation of time spent in postdoctoral positions growing, as is the average is the major con- important correlate of this situation An career. an independent research enterprise. fellows to the national research tribution made by postdoctoral fellows: 27 in the the School of Pharmacy had 32 postdoctoral they will work. In 2005, of Pharmaceutical Sciences, four in the Department Department of Pharmaceutical Practice and Science. and one in the Department of Pharmacy Health Services Research, of Maryland School of Pharmacy last Postdoctoral appointments at the University may provide well thought-out some departments between one and three years. However, or five years in duration. postdoctoral experiences that are four

o

n

r

o

i

a

t

t i

i b o n m a • 12 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 15 CHEROKEE AMY WILEY, (third from left). Under (left), and MAGALY RODRIGUEZ DE BITTNER, MAGALY

(second from left) and (right) celebrate with program co-

, L assistant professor and director of the Drug directors, The 2004-05 residents held their graduation The 2004-05 residents the Belvedere Hotel in banquet on June 22 at Pharmacy Residents, Baltimore. Community MEG MILL, PharmD LAYSON-WOLF, PharmD LAYSON-WOLF, their mentorship, Mill completed her residency and is currently a clinical at Giant Pharmacy, pharmacist at an anti-coagulation clinic at Union Memorial Hospital. Wiley completed and her residency at CVS HealthConnections, is currently a clinical pharmacist at the North Education Centers. Area Health Carolina PharmD PharmD , L Information Center (left) presents her drug information resident, Sharon Kim Information Center Park, PharmD ’04 (right) with her certificate of completion. RACHEL BONGIORNO, PharmD The Residency and Fellowship Training Program continued to flourish Program continued Training and Fellowship The Residency AMIE Residency and Fellowship Training and Fellowship Residency completing their year with seven residents beginning and during the 2004-05 enhanced a variety of activities and settings, the residents programs. Through meet the demands teaching, and critical thinking skills to their clinical, research, this in program Residents in the profession of pharmacy. of changes occurring to choose among 10 different specializations. have the opportunity (left), prac al t assistant ic ic , n e i • l t c e

a

• c

e

h

r i

n a focus

g c

t

s

n L

k PharmD NICKI BRANDT, at the graduation banquet. After com- Taggart-Blaszczyk, pleting her residency, where she is currently moved to Texas Tech an assistant professor at Texas School of Pharmacy. professor and director of the geriatric pharmacotherapy residency program (right) congratulates her resident TAGGART-BLASZCZYK, PharmD

e

i i

l t

s a p • “The research project has been extremely Upon completion of his postdoctoral train- Hatefi, along with Hamid Currently, interesting and motivating,” he says. ing, Hafeti considered returning to the biotech but is now actively or pharmaceutical industry, pursing a position in academia. “I can be freer in academia to develop and pursue my own research ideas,” he says. “I have many ideas that I would like to test in the lab and hope that one can make its way to the clinic. I hope that I can someday be known as a gene therapist who made an impact in this field.” Ghanderhari Megeed, Zak have a patent and for polymer pending for a recombinant protein systemic gene delivery to breast cancer cells. postdoctoral fellow in

a

“I decided to quit my well-paid job and ARASH HAFETI, PhD, come to Maryland to satisfy my fascination with says Hafeti. the concept of gene therapy,” Under the mentorship of Hamid Ghandehari, PhD, associate professor and director of the Delivery, for Nanomedicine and Cellular Center Hafeti works on the biosynthesis of recombi- nant polymers for cancer gene therapy. the Department the Sciences, of Pharmaceutical holds a PhD in Pharmaceutical Sciences from the University of Alberta and a PharmD from Shahid Beheshti University in Iran. He came to the School in 2003 after working as an R&D research scientist at Patheon, Inc., a pharma- ceutical company in Canada. 14 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 17 | | | | | | | | | $682,644 $599,999 $15,511 $31,545 | | | | $30,000 $110,000 $110,000 $83,040 $62,766 | | | | $20,000 | | $154,090 $60,000 | | $26,500 | harmacy 75,000 P Blood Institute $181,167 Inc. Fellowship-Lilly Association Association Association Baltimore $37,774 $25,317 $ aryland Therapy Management Program Healtharyland Therapy Department of Maryland reast Cancer Patients’ Preferences for Initial Localreast Cancer of Health National Institutes NABLE CKF & BHCA Access, Baltimore HealthCare NABLE Tobacco Cessation Grant Grant Cessation NABLE Tobacco Baltimore City azarus-ENABLE Commmunity Health Worker Program Health Worker azarus-ENABLE Commmunity The Lazarus Foundation L Starting Dose and Persistence of Geodon amongMedicaid Patients Prescribed Drugs: Tier Placement for Commonly Formulary Index of Accessibility Benchmarking & Creation Pfizer Pharmaceuticals Pfizer Pharmaceuticals Prescribed Drugs: Tier Placement for Commonly Formulary Index of Accessibility Benchmarking & Creation Pfizer Pharmaceuticals Proposal - Wilson P60 Eye $15,000 Specialty Injectables Benchmarking Study/Part 2-BCBSA $25,000 Blue Shield Blue Cross Specialty Injectables Benchmarking Study/Part 2-BCBSA $240,850 Blue Shield Blue Cross Specialty Injectables Benchmarking Study/Part 2-BCBSF Blue Shield Blue Cross Institute National Eye Fink-R21 DK6412601A1 in African-Americans Hypertension Telemanagement Bon Secours Sub-award: Partnership Program to Reduce National Heart, Lung, and Disparities Cardiovascular Bon Secours Baltimore Health Early Educational Program to University of Maryland, Pfizer/Medicaid UMB/Disparities & Pharmacoeconomics Pfizer Pharmaceuticals of COPD Utilization and Cost Patterns, Health Treatment System Pfizer Pharmaceuticals Service A Compendium Outcomes: UUI Treatment University of Maryland Surgical Baltimore Partnership Program to Reduce DisparitiesCardiovascular Pfizer Pharmaceuticals National Heart, Lung, and Blood Institute M B E Bon Secours Sub-award: Partnership Program to DisparitiesReduce Cardiovascular Management Pharmacoeconomic Formulary Bon Secours Baltimore Eli Lilly Health System E agaly Rodriguez de Bittner agaly Rodriguez onald Fedder raduate Student Therapy & Systematic Therapy $27,554 rofessor rofessor Study Agreement Evaluation and Mental Hygiene, Board of Faculty Mentor, Sheila Weiss) Mentor, Faculty esse Cooke C. Daniel Mullins, Co-PI Joseph Finkelstein, PI-SOM C. Daniel Mullins, Co-PI Shaya, Co-PI Fadia Elija Saunders, PI-SOM Pradel, PI Francoise Stephen Bartlett, PI-SOM Shaya Fadia Shaya, Co-PI Fadia Elija Saunders, PI-SOM M J D Co-PI; Donald Fedder, PI-SOM Kelleher, Catherine C. Daniel Mullins G ( P Professor Associate ProfessorAssistant Professor Increase Live Kidney Donation Program (COPD Fellowship) Associates $70,000 P $20,000 $4,185,782 TH SERVICES .Total: EPARTMENT INVESTIGATOR PROJECT TITLE SPONSOR | PROJECT TOTAL ESEARCH D DEAN’S OFFICE Dept.Total: DEPARTMENT OF PHARMACEUTICAL HEAL R Dept ------associ , hD target, educate, , Linda Simoni-Wastila, PhD Department of , This study also examines the pat- Findings will also inform preven LINDA SIMONI-WASTILA, P LINDA SIMONI-WASTILA, ate professor Pharmaceutical Health Services Research, was awarded a $408,000 grant from the National Institutes of Health for her research, “Prescription Drug Abuse in Adolescents and Young Adults.” The objectives of this study are to: 1) determine the prevalence of prescription drug non-medical use, abuse, and dependency among community-dwelling adolescents and young adults aged 12-25; and 2) elicit the risk and protective factors associ- ated with such use. terns of non-medical prescription drug use, with a focus on individuals who only use prescription-type drugs relative to those who use prescription-type medications in conjunction with other illicit drugs, such as marijuana, hero in, and cocaine. Findings from the study will fill an important gap in policy makers’, researchers’, and clinicians’ understanding of problem use of pre scription drugs with addiction poten tial in these two vulnerable age groups. tion and treatment providers with an improved understanding of prescrip tion drug abuse, thereby allowing them to better identify and treat youth and young adults with prescription drug abuse problems. - , Tom C. Dowling, Tom PharmD, PhD , clear- associate professor , hD James Polli, PhD This project will evaluate an experi GRANTS AND AWARDS AND GRANTS TOM C. DOWLING, PharmD, PhD JAMES POLLI, P associate professor, Department of associate professor, Pharmacy Practice and Science, was awarded a $222,750 grant from the National Institutes of Health, National Institute of General Medical Sciences, for his research, “IVIVC Model for Renal Drug Clearance.” mental kidney cell line (in vitro) and its ability to predict renal drug ance and nephrotoxicity in humans (in vivo) using translational research approaches. Undergraduate pharmacy students interested in postgraduate training will participate in this series of projects. Department of Pharmaceutical Sciences, was awarded a $1.5 million grant by the National Institutes of Health for his project, “Substrate Requirements of the Bile Acid Polli seeks to better Transporter.” understand what types of compounds are amendable to be taken up by the A long-term gut’s bile acid transporter. objective is to use the bile acid trans- porter to design orally bioavailable prodrugs of compounds that otherwise are not absorbed. - associate Hamid Ghandehari, PhD , Center for Center , associate profes ellular Delivery, , hD Department of Pharmaceutical oop, PhD ,

Department of Pharmaceutical The five-year award is focused on

, ancer.” This research aims at local- ancer.” Nanomedicine and C has been awarded a $1.1 million grant by the National Institutes of Health for his project, “Engineering Polymers for Gene Therapy of Head and Neck C ized adenoviral gene delivery at the site of head and neck tumors using novel recombinant polymeric matrices. sor HAMID GHANDEHARI, PhD ANDREW COOP, P Andrew C professor Sciences, and director Sciences, received a Career Training Sciences, received a Career (K02) from the National Institutes Award of Health, National Institute on Drug Abuse for his project, “Reversing the of Drugs of Abuse.” Effects Toxic the development of therapeutic agents to prevent constipation in patients receiving analgesics for chronic pain and also agents for the treatment of cocaine and methamphetamine over- provide Awards Training dose. Career newly independent researchers a mechanism by which they can devote up to 75 percent of their professional effort on developing their specific area of research. 16 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 19 $68,463 $970 $12,001 | $12,507 $96,724 $340,305 $298,534 | | $5,000 | $50,000 $27,600 $2,850 | | | | | | | $2,500 $111,375 | $290,941 | $91,494 | | $17,977 $20,000 | | $44,698 | $23,771 | etirement Education $287,322 $881,073 $298,534 $47,013 $145,743 $15,987 etirement Education etirement Education harmacists Foundation harmacists Foundation R | | | P R Medical System | | | National Institute of General Medical Sciences Pharmacy R are Management Project on Aging and Commission ontract Retirement Education ounty Department of Aging on Aging and Commission ealthScope C mniCare-Clinical/Consultation Position Position mniCare-Clinical/Consultation Omnicare, Inc. SHP Therapeutic Position Statement on the Statement Position SHP Therapeutic Health-Systems Society for American SHP Therapeutic Guideline on Antimicrobial Prophylaxis Guideline on Antimicrobial SHP Therapeutic Society for Health-Systems American altimore Beneficiary Outreach Program (CARE) altimore Beneficiary Outreach on Aging and Commission altimore City CARE and on Aging Commission altimore Integrated C altimore C VIVC Model for Renal Drug Clearance VIVC Model for Renal Drug Improvement of Pharmacy Services, Upper Eastern Shore Eastern Shore Hospital Center Improving Pharmacy Services, Spring Grove Spring Grove Hospital Center Improvement of Pharmacy Services, Eastern Shore andUpper Shore Hospital Center Eastern Shore Hospital Center Improvement of Pharmacy Services, Walter P. Carter Center Center P. Carter Improvement of Pharmacy Services, Walter Center P. Carter Walter Improvement of Pharmacy Services, Perkins Hospital Perkins Hospital Center Clifton T. A B Needs Assessment for Pharmacist Pain Management Clinical Pharmacy ServicesUMMS Contract Novartis Improving Pharmacy Services, Spring Grove, Supplement Center Spring Grove Hospital University of Maryland Enhancement of Pharmacy Services, Rosewood Center Rosewood Hospital Center Project: Disease State Mngt Pharm Care BCBS Residency CareFirst Giant of Maryland, LLC Blue Shield Blue Cross CareFirst A O I of Diabetic Nephropathy in Hispanic-AmericansEvaluation of Clinical American College Traineeship Diabetes Patient Care ASHP Foundation Pharmacy Community Pharmaceutical Care ASHP Foundation Center P. Carter Improvement of Pharmacy Service, Walter Pharmacies NeighborCare Center P. Carter Walter CVS Residency Pharmacy Program CVS B Analysis of PAH and Iothalamate in Plasma and of Pittsburgh University Urine Samples from the PTT Liver Study B B H icole Brandt achel Bongiorno achel homas Dowling ssistant Professorssistant Chlorideof .9% Sodium Institutional Use Pharmacists Foundation ssistant Professor Professor Professor A Mary McPherson ProfessorRobert Michocki Professor David Moore Assistant Professor Program Certifcate Jason Noel Assistant Professor Magaly Rodriguez de Bittner Professor Gary Smith Professor R N T Associate Professor Stuart Haines Cherokee Layson-Wolf Raymond Love Assistant Professor A EPARTMENT INVESTIGATOR PROJECT TITLE SPONSOR | PROJECT TOTAL RACTICE AND D OF DEPARTMENT PHARMACY P SCIENCE | | | | | | $33,551 $176,910 $176,910 | $29,883 $122,874 $203,526 $10,970 ($14,850) $7,065 $15,879 $227,071 | | | | | | | | | $20,009 $8,025 $99,963 $26,443 | | | $17,256 $3,670 | | | enter $222,750 $558,745 $129,330 | | | $16,182 | edical C buse Mental Hygiene Mental Hygiene $50,000 Corporation Administration M Authority Mental Hygiene A $5,400 $59,000 $1,000 Mental Hygiene TC Strategies Brown University HOPWA Project for Medically Fragile HIV Fragile HOPWA Project for Medically for the Homeless, Health Care : enter Core Aenter Core Administration Veterans Drug Use, Medical Services Use and Work StatusUse and Work Drug Use, Medical Services University of Massachusetts Disabled Medicaid Recipients (MMIG)Disabled Medicaid Recipients $34,744 rug Use & Spending rug Use & Spending $104,822 niversity of Massachusetts Contract for Service- Contract niversity of Massachusetts University of Massachusetts ONNECT x epper C rescription Drug Abuse in Adolescents and Young Adults Young Abuse in Adolescents and rescription Drug National Institute on Drug Hospital L PS-Post BBA Changes in Rural stablishing the Value of Stable Prescription Coverage of Stable Prescription stablishing the Value Johnson Robert Wood rends in Antipsychotic Use and Other Problematic Problematic Use and Other Antipsychotic rends in Department of Health and n Medicaid-MPC Service Contract Medicaid-MPC Service Contract Department of Health and P and Homeless Persons Inc. Pharmacists’ Response to Bioterrorism Electronic Training Pharmacists’ Response to Bioterrorism Electronic Training of Health and Department Nebulizer Adherence in Minority Children with Asthma Johns Hopkins University Products AmendmentAvon Company Avon Frequency of Medication Usage in Pediatric Population: Frequency Westat Elders Among Community-Dwelling Predicting Transitions National Institute on Research for Minority Health Services Center Information Agreement Provide Medical Combe University Howard Baxter Healthcare Corporation Inc. Combe, StabilizationHRSA-Poison Center Recurrences of Local Coagulopathy Retrospective Evaluation Associated with Antivenom Therapy Denver Health and Hospital Baxter Healthcare Health Resources and Services Authority P C P E from SubstanceNeuroscience TV to Steer Teens Infoculture T MPC Monitoring for Terrorism/Public Health Threat MPC Monitoring for Terrorism/Public Department of Health and Surveillance of the RADARS by PCC: A Pilot Study Denver Health and Hospital D R i U Abuse: Evaluation Motivational Interviewing to Reduce Smoking Society American Cancer Office Based Opioid Treatment (Supplement) Office Based Opioid Treatment Highway Safety Program Minigrant Open Society Institute Students Motivating Peers to Quit Smoking Hopkins University Johns of Health and Department o-PI ommasello Geriatric Pharmacotherapy enise Orwig, PI-SOM nthony T ruce Stuart, C ruce Stuart ssociate Professorssociate Facilities Meds in Long-term Care Human Services inda Simoni-Wastila arke-Davis Professor for Medicare Beneficiaries Foundation f Associate Professor Bruce Anderson Associate ProfessorIlene Zuckerman Associate Professor Data Analysis and Report A Comprehensive Associate Professor Aging Julie Zito B D A B o L P A $3,909,414

.Total:

EALTH SERVICES EALTH EPARTMENT INVESTIGATOR PROJECT TITLE SPONSOR | PROJECT TOTAL D OF DEPARTMENT PHARMACEUTICAL H RESEARCH Dept DEPARTMENT OF PHARMACY PRACTICE AND SCIENCE 18 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 21 | $33,363 $134,325 $133,650 $218,017 | | | | $92,760 | $50,000 $45,000 $45,000 $99,437 | | $231,289 | | $326,544 | $127,097 $127,097 $50,000 $111,375 $37,936 $111,375 | $148,500 | | | | | edical Sciences | $270,771 $244,283 $42,132 $40,000 $25,000 Blood Institute | Digestive & Kidney Diseases | Foundation Cancer | National Institute on Drug Abuse National Institute on Drug Abuse $42,722 | | Emerging Infectious Diseases Research M orce Field for Proteins and Lipids orce Field for Proteins and Lipids University Cornell rugs Continuation olarizable F roposed Modeling Study of Xenaldial-CSCR Study of Xenaldial-CSCR roposed Modeling Unihart Biotech Pharma NV 56lck Inhibitors as Potential Immunosuppressive Drugs as Potential Immunosuppressive 56lck Inhibitors as Potential Immunosuppressive 561ck Inhibitors Institute Cancer National Institute National Cancer nergetics of Oligonucleotide Conformational Heterogeneity Conformational nergetics of Oligonucleotide of General National Institute hort Duration Kappa Opioid Antagonists hort Duration Kappa Opioid argetable Polymer-Antiangiogenic Drug Conjugatesargetable Polymer-Antiangiogenic U.S. Army nhibition of the Breast Cancer Marker MUC1 by Marker MUC1 Cancer of the Breast nhibition Breast Cancer Susan G. Komen Regulation of FOXO Transcription Factors and Apoptosis Factors Regulation of FOXO Transcription Prevention by Curcumin in Prostate Cancer U.S. Army Development of Novel Drugs for Prostate Cancer Therapy Development of Novel Drugs for Prostate Cancer U.S. Army Porous Silicon Particles for Oral Drug Delivery Structural Biology of the Apical Bile Acid Transporter National Institute of Biomedical National Institute of Diabetes & Breast Cancer in Riboflavin Trafficking Race/Ethnicity/Immunity/Progesterone andPreterm Birth Smooth Muscle/Endothelium Pregnancy Effect on Vascular National Heart, Lung, and Susan G. Komen Breast for Disease Control Centers I P p p D E P S T Drug Intestinal Permeability In Vitro-In Vivo Correlation Characterization of Biorelevant Dissolution MediaDevelopment of Polymer-linked Nitroxides as and Drug Administration Food Shire Labs Studies into Anthrax Survival from Oxidative Killingby Phagocytes Shire Pharmaceutical Development Institute National Cancer of Atlantic Regional Center Middle EPR Imaging for In Vivo Physiology Low Frequency Very Development of ERK Docking Domain Inhibitors University of Chicago Development of Novel MAP Kinase Inhibitors to Proliferation Inhibit Airway Smooth Muscle Cell Institute National Cancer School of Medicine Excellence for Biodefense and ellow Therapy for Systemic Breast Cancer atthew Metcalf aculty Mentor, Andrew Coop) aculty Mentor, lexander MacKerell njan Nan raduate Student ssistant Professorssistant Indole-3-Carbinol the Chemopreventative, Foundation rofessor Interactions Receptor ostDoc F Neuronascent, Inc. F nsong Lee nsong Assistant Professor Rakesh Srivastava Peter Swaan Associate ProfessorPeter Swaan, Co-PI PI-SOM Weiner, Carl Peter Swaan, Co-PI PI-SOM Weiner, Carl Imaging and Bioengineering I A A P M G ( A P James Polli Associate Professor Gerald Rosen Issac E. Emerson Professor Agents Contrast Specific Tumor-MRI Paul Shapiro Associate Professor EPARTMENT INVESTIGATOR PROJECT TITLE SPONSOR | PROJECT TOTAL CIENCES D OF DEPARTMENT PHARMACEUTICAL S $14,000 $33,510 $25,733 $34,329 $34,329 $263,959 $35,027 | | | | | $35,000 | | $29,200 $11,441 | | $29,240 $30,000 $201,800 $140,089 | | | $30,000 | | $155,093 | $247,750 | $252,450 $174,862 $7,000 $222,750 $97,427 $25,000 $185,625 | | Respironics Inc. | | | Health | | ocaine Properties University of Mississippi oxic Effects of Drugs of Abuse oxic Effects of Drugs of Abuse National Institute on Drug Abuse Agonist Activity u pioids with Delta Antagonist and pioids with Delta Antagonist Institute on Drug Abuse National evelopment of Novel Agents with Anti-C evelopment of Novel Agents eversing the T onsortium for Industrial Pharmaceutics Educationonsortium for Inc. McNeil-PPC, pacer & Nebulizer Development pacer & Nebulizer Development ynthesis of Analogs of Xenaldial ynthesis of Analogs Unihart Biotech Pharma NV ynthesis of Neurogenic Agents ynthesis of Neurogenic Agents Inc. Neuronascent, mproving Asthma Communication in Minority Families Families in Minority Asthma Communication mproving Johns Hopkins University mproving Asthma Communication in Minority Families Communication mproving Asthma Johns Hopkins University Engineering Polymers for Targeted Breast CancerEngineering Polymers for Targeted Curing: Coat Analysis and Prediction of Tablet Center National Cancer Rohm America of Poly Amidoamine Dendrimers Transport Transepithelial National Institute of General Benztropine Analogs, Cocaine Abuse Pharmacotherapies Abuse Benztropine Analogs, Cocaine National Institute on Drug Abuse Microparticles for Microarterial Imaging and JDA Medical Technologies Alpha Therapy forAngiogenesis Targeted Project Solid Tumors/ARCA Alliance American Russian Cancer S in Breast CancerRiboflavin Trafficking Analysis of the Disaccharides of Glycosaminoglycans (GAGs) GlaxoSmithKline Health Research Group Women’s C S Therapy Gene Cancer for Breast Silk-Elastinlike Copolymers U.S. Army I I S O M PAT Applications for Tablet Film Coating Film Coating Applications for Tablet PAT and Drug Administration Food Therapeutic Interventions for HIV-1 CNS Sequestration National Institute of Mental Engineering Polymers for Gene Therapy of Institute National Cancer R D Head and Neck Cancer 3rd Annual Symposium on Nanomedicine and Drug Delivery of Biomedical National Institute Imaging and Bioengineering Delivery of Therapeutic Agents by ModulatingTight Junctions with ZOT National Institute of Biomedical Imaging and Bioengineering ona Tsoukleris ona Tsoukleris ndrew Coop ndrew Coop ichard Dalby ssociate Professor Inc. Neuronascent, ssociate Professor ssociate arry Augsburger alph Shangraw Professoralph Shangraw (CIPET) and Research Graduate Student Medical Sciences Stephen Hoag Kelly Kitchens Professor SB42432 in Human Plasma After Dosing with Hamid Ghandehari, Co-PI Bruce Line, PI-SOM Hatefi, Arash PostDoc Fellow Gene Therapy Hamid Ghandehari Visiting Scientist Vanessa D’Souza Vanessa Natalie Eddington R A R Associate Professor Radiotherapy L A M A Associate Professor via NIR Spectroscopy and In Vitro Dissolution (Faculty Mentor, Hamid Ghandehari) Mentor, (Faculty Professor $6,178,027

EPARTMENT INVESTIGATOR PROJECT TITLE SPONSOR | PROJECT TOTAL RACTICE AND Dept.Total: DEPARTMENT OF DEPARTMENT PHARMACY P SCIENCE OF DEPARTMENT PHARMACEUTICAL SCIENCES D 20 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 23 Pharmaceutical continued its work to improve drug continued experimental collaborations along with the Department of Pharma- , developed a 2-credit continuing education developed a 2-credit PRC also hosted its first open house in FY05. Faculty, PRC also hosted its first open house in . answered more than 68,000 calls in 2005. Of these, about CHOOL OF PHARMACY CENTERS PHARMACY OF CHOOL S ffice of Substance Abuse Studies (OSAS) ffice of Substance Abuse Maryland Poison Center Center on Drugs and Public Policy (CCDP) Center (CADD) Drug Design Center Computer-Aided Peter Lamy Center on Drug Therapy and Aging Peter Lamy Center O years old and younger. The School of Pharmacy centers continued to provide a focus for a variety of research, a focus for a variety continued to provide of Pharmacy centers The School several of the Below are just year. during the 2004-05 academic activities clinical, and achieved over the past year. many accomplishments The The initiatives. therapy for aging adults through innovative research, education, and clinical program on CD ROM titled, “A Primer for Pharmacists on Buprenoorphine Treatment of Treatment for Pharmacists on Buprenoorphine Primer titled, “A program on CD ROM on office-based opioid treat- The office also conducted a clinical trial Opioid Addiction.” in New York. Drucker of Montefiore Medical Center Ernest with Dr. ment in collaboration community pharmacies, pharmacists dispense methadone from In this clinical trial, care of methadone pharmacist involvement in the community-based creating a model for to continue this project. OSAS is seeking additional funding maintenance patients. with additional support the National Institute on Drug Abuse Current funding is from from the Open Society Institute. PharmD, was promoted to director of the Doren Hsu, In June, Van came to mingle and learn about data staff, and students from across the school how PRC can support their research. warehousing and analysis services and The and the University of Maryland Marlene and with scientists in the School of Medicine, In addition, as well as the School of Pharmacy. Center, Stewart Greenebaum Cancer the Burnham Institute; Albert Einstein Medical CADD collaborated with scientists at and the Institute of Organic & Medical Center; Southwest University of Texas College; Greece. From Foundation, National Hellenic Research Pharmaceutical Chemistry, several these collaborative studies, eight manuscripts were published in 2004-05 and patents are pending. The Research Computing Center (PRC) Center Research Computing 38,000 were human exposures to poisonous substances—more than half in children 38,000 were human exposures to poisonous substances—more than half in 5 ceutical Sciences, hosted a one-week regulatory program for 14 Japanese scientists ceutical Sciences, hosted a one-week and the Japanese version of the FDA. CCDP from Japanese pharmaceutical industries of Maryland School of Law on the drug also co-hosted a program with the University by C-SPAN. The program was broadcast importation debate in October. The $259,875 $222,750 | | $28,763 | $41,792 $41,347 $334,125 $119,523 $13,080 $20,000 $222,750 nfectious Diseases Infectious Diseases National Institute of Allergy and National Institute of Allergy I | | | | Administration and Drug Food | | | unction, and Pathogenesis National Institute of Allergy and OR Phosphorylation in Opioid Tolerance and Dependence and Dependence Tolerance OR Phosphorylation in Opioid Institute on Drug Abuse National OR Phosphorylation in Opioid Tolerance and Dependence Tolerance OR Phosphorylation in Opioid Abuse National Institute on Drug eme Oxygenase: Structure, F Dysenteriae eme Acquisition in Shigella opamine and Psychostimulant Regulation of Neurotrophin Regulation opamine and Psychostimulant on Drug Abuse National Institute sychostimulant Agents-Diversity Supplement sychostimulant ignaling-Diversity Supplement ignaling-Diversity ignaling Pathways in the Neurobehavioral Actions of in the Neurobehavioral ignaling Pathways Abuse National Institute on Drug ignaling Mechanisms in Dopamine Receptor Synergism Receptor Synergism in Dopamine Mechanisms ignaling National Institute on Drug Abuse ntegrating Design of Experiment Methodology and ntegrating Design of Experiment H S P M I Magnetic Resonance Imaging of Polymeric Drug Delivery U.S. Army Analysis of Super Disintegrants Functional U.S. Pharmacopeia Convention M H for Science and Risk Statistical Simulation Approach S D S

ollab • c or g a n t i i o d n ngela Wilks shiwel Undie shiwel n ssociate Professor ssociate Professor ssociate Professor ssociate in Xie ia Bei Wang

A Bahar Zarabi Na Zhao Graduate Student A L J A Graduate Student Stephen Hoag) Mentor, (Faculty Graduate Student Hamid Ghandehari) Mentor, (Faculty Larry Augsburger) Mentor, (Faculty Solid Tumors in Breast Cancer Systems A A

u •

f r

e • focus

s

t

e

r a

o

r

p

$14,293,223 c

p

WARDS h u s • AL GRANTS

EPARTMENT INVESTIGATOR PROJECT TITLE SPONSOR | PROJECT TOTAL CIENCES D OF DEPARTMENT PHARMACEUTICAL S TOT AND A 22 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 25 - rowt • g h • s c n h

o a

i

l

t

l

u e

focus

n b

i

g

r

e

t

s

n

o • c The School continues to grow due to the unrelenting success of our faculty in attracting extramural funding for research, education, and service. Sources of revenues supporting basic operations increased by 10 percent over the last fiscal year as a result of the growth in contract and grant revenues. Restricted funds now make up 54 percent of the School’s revenues supporting basic operations. As the campus struggles with unavoidable increases in energy costs, health insurance benefits, and building and equipment main tenance, individual schools are required to contribute more to campus operations. Tuition revenues have been used to offset declines in the School’s state general fund allocation. The School and campus, working in conjunction with federal officials, were successful in obtaining a $491,000 grant that will support a new 275-seat auditorium, which will reduce the overcrowding in our PharmD programs that has existed for more than a decade. $597,778 FY 2005 $138,435 $3,040,885 $1,244,968 $1,749,042 $451,465 $451,465 $451,465 $403,000$597,778 $403,000 $504,074 ($938,334) ($938,334) $2,902,450 INANCIALS unds F wards $14,293,223 $14,293,223 ellowship Revenues *

Sources of Operating Revenues Supporting the School Revenues Supporting Sources of Operating ontract & Grant A Eliminations-Research gifts that have been reported both under * contract & grant awards and as gifts by the campus Total Sources of Funds Supporting the School Sources of Funds Total $41,182,349 Total Sources - Basic OperationsTotal $18,213,656 Mgt., Facilities Campus-Funded $15,271,237 Administration, Student Services & Institutional Costs $33,484,893 $7,697,456 Endowment Income State General Fund AppropriationState General Fund Program TransferLess Campus Fees & Tuition (from indirect costs) Funds Federal $4,200,536Other $4,200,536 Benefits Fringe Campus-Funded ($388,024) ($388,024) Scholarship/F $328,388 $328,388 $7,572,683 $2,155,705 $7,572,683 $2,155,705 $18,546 $18,546 SOURCES RESTRICTED UNRESTRICTED TOTAL UNRESTRICTED RESTRICTED SOURCES Designated Research Initiative F C Eliminations Gifts Auxiliary & Miscellaneous 24 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 27 PharmD ’97 , PhD ’86 PhD ’99 , , MS ’50 BSP ’55 PhD ’98 , BSP ’57 , , BSP ’85 PharmD ’96, MS ’73 , , BSP ’79 BSP ’81 PhD ’90 BSP ’82 , BSP ’73 BSP ’94 PharmD ’96, BSP ’71 , PharmD ’99, BSP ’73 BSP ’57 , BS ’88 , BSP ’77 BSP ’80 , BSP ’62 BSP ’51 BSP ’81 BSP ’82 , BSP ’85 , PharmD ’98 , BSP ’60 BSP ’70 , , , , , , PharmD ’00, BSP ’77 , , PharmD ’99 , , , , , MS ’63 BSP ’47 , BSP ’81 PhD ’99, BSP ’93 , MS ’87 BSP ’73 BSP ’68 , , BSP ’70 , , , , , PharmD ’01 BSP ’78 PharmD ’00, BSP ’79 , BSP ’79 , , BSP ’52 , , , BSP ’51 Blatt Burke , . . Allman Brzeczko . yd . Janice B. Connelley ranklin W rancis J. Bublavek Century Club Century $100-$249 Lawrence M. Abrams James D. Babb Raymond D. Bahr Ronald L. Block Jeffrey M. Brewer Albert W Gina Patrice McKnight-Smith Sharon T Joseph S. Fannella Adolph Baer Maura Patricia Murphy Brian L. Schumer Lisa L. Booze F David L. Booze Ruth S. Blatt Barbara B. Bedell Phyllis A. Bernard Miriam S. Bronstein Marsha E. Alvarez William P. Beierschmitt Charles R. Downs Sandra L. Becker Alvin H. Burwell Edward P. Becker Louis M. Bickel Donna M. Barrett Wayne A. Dyke Wayne Mark A. Anderson Stephen R. Anderson Dolores A. Ichniowski Ronald E. Lay F Kathleen T Mary W. Connelly Mary W. John J. A Shelby D. Reed Laci L. Brown David M. Arrington Steven Agapis Ronald P. Kleiman Thomas James Pfaff Jerome A. Berger Steven J. Miller Alison Davitt for Director of Development and Programs Special Gifts 410-706-4415 [email protected] PhD ’99, BSP ’92 PharmD ’04 BSP ’75 PhD ’50, MS ’44 , BSP ’70 , , PharmD ’86 , BSP ’86 PharmD ’93 , BSP ’53 , BSP ’93 PharmD ’00 PharmD ’98 , , BSP ’70 , , , , , BSP ’86 . BSP ’87 BSP ’84 BSP ’59 BSP ’76 BSP ’50 , BSP ’83 PharmD ’02, BSP ’78 BSP ’60 BSP ’59 , , PharmD ’01 , , BSP ’58 , BSP ’82 , , , PharmD ’96 PhD ’93, BSP ’85 , , PharmD ’85 , BSP ’74 , BSP ’67 BSP ’54 , , BSP ’58 PharmD ’98 MS ’83 , , BSP ’60 , , , , , PhD ’98 , PharmD ’04 PharmD ’04 utoh PharmD ’02 , PharmD ’01 , , , PharmD ’04 , , regoe armichael Pollhammer oder Swope, Jr ohen oigt . esfayohannes . an Doren Steven P. George ynette R. Bradley-Baker sion H. T 1841 Club Enitan Adesegun Patrick J. Park Virginia Lambrow Louise Q. Leach Abigail M. Strawberry Vincent E. Pearson Irene L. Winters Phillip L. Marsiglia Ming-Haw Liu Morton D. Kramer William J. Zimmerman Loreen Afua W Robin L. Paluskievicz Samuel Lichter Doris R. V Margaret Dorn-Muller Brett M. Behounek Stuart Tilman Haines Renee M. Hilliard Gaytrice K. Rucker Karen M. Kabat Sally V Francis X. Muller Francis L Sorrell L. Schwartz Kan Chan Ku Mary Lynn McPherson Mary Lynn John Anthony Scigliano Howard K. Besner Richard W David M. Y T Kelly S. Park Clara K. Song Bruce Stuart George W Xiaoqang Ren Michael B. Rodell Gerald I. C Stephen Needel Joseph H. Morton Robin Gardner Smith Florence E. Raimondi Charles H. T Patrice M. C to join our special giving clubs, please contact the Office of Development Office please contact the special giving clubs, to join our or more information on ways to make your gift to the School of Pharmacy to the School of to make your gift on ways or more information r nd Alumni Affairs: nd Alumni o a Ewing Michele Development Executive Director of and Alumni Affairs 410-706-3816 F [email protected] PharmD ’80 , BSP ’79 BSP ’92 BSP ’88 PharmD ’93, , , , , PharmD ’00 PhD ’95, PharmD ’92 PhD ’67, MS ’65, PhD ’66, MS ’63, PhD ’88, BSP ’83 BSP ’72 BSP ’86 BSP ’56 BSP ’55 BSP ’77 , , , PharmD ’75, BSP ’71 , , BSP ’57 PhD ’96 , BSP ’74 , , BSP ’50 , BSP ’70 BSP ’92 , BSP ’72 PhD ’95 , , , , , , , * BSP ’87 , PharmD ’99 BSP ’63 PhD ’86 , BSP ’80 PharmD ’01, BSP ’93 BSP ’74 PharmD ’97 BSP ’72 PharmD ’04 BSP ’79 PhD ’94 , , BSP ’72 , , , , , , , , , , , aulfield BSP ’56 Feinberg edder , ornias Ellinger ossler, Jr. ossler, . aughn riedman . BSP ’86 BSP ’60 BSP ’62 BSP ’79 Apothecary Club $250-$499 Larry L. Augsburger Stephen L. Disharoon Joanne S. Enterline Thomas S. Brenner Poonam G. Pande Nicole J. Brandt Randy R. Delker David D. MacLaren Larry J. Brendle Stephen B. Bierer James D. Edwards Russel A. Gobeille Christopher E. Thomas, PharmD ’89, Margaret V Frances Spaven Frances Melanie D. Chapple John P. Kane Donald M. Kirson Michael J. Bochniewicz Rajesh E. David Joseph Libercci Madeline V Ronald D. Guiles S. Howell Forest M. David Richman Kristine W Girish S. Pande Ralph Engel Donald O. F Sherry N. Berlin Keith E. Broome, RPh Robert J. Michocki James R. Ritchie Kimberly L. Barnett Julian M. F Nicholas C Michael J. F Kevin J. Chapple Suzanne M. C Dennis L. Eaton John E. Braaten BSP ’49 BSP ’54 , , BSP ’78 MS ’51 Deborah Cooper William J. Cooper Phong D. Do, PharmD ’04 Natalie D. Eddington, PhD ’89 Russell B. Fair J. Philip Fink, BSP ’79 PhD ’83, MS ’81, Mark George Fletcher, DSC ’87, PhD ’55, William M. Heller, Alice H. Hill, PharmD ’93 J. Hryszko, BSP ’74 Walter Joseph L. Johnson, III, MS ’76, BSP ’73 Robert R. Kantorski, BSP ’62 Anne B. Leavitt Raymond C. Love, PharmD ’77 Michael Luzuriaga, BSP ’70 Edward Marlowe, PhD ’63 C. Daniel Mullins Richard P. Penna Joyce Pinco Robert G. Pinco PharmD ’83 Magaly Rodriguez de Bittner, Bruce D. Roffe, MS ’78 Melvin N. Rubin, BSP ’55 David M. Russo, BSP ’79 Larry E. Small, PhD ’81, MS ’76 Diane Smith Gary H. Smith BSP ’76 Alex M. Taylor, David R. Teckman PharmD ’96, BSP ’58 George C. Voxakis, Diane K. Wills, PharmD ’00 F. Wills, PharmD ’00 Terry Phyllis Brill Wingrat, BSP ’50 Dean’s Club $500-$999 Alfred Abramson, BSP ’56 Adams Marie V. Adams, BSP ’68 Robert W. Jay Royce Brinsfield, BSP ’58 BSP ’83 Scott M. Ceccorulli, David Ross Chason, BSP ’71 Cohen Betty W. Gilbert Cohen 61, 73 ’ ’ * O 71 ’ 63, MS ’ 96, BSP 63 ’ ’ 97 63 ’ ’ 53 98 96 ’ ’ ’ 92 ’ 73 ’ 65 73, MS 74 ’ ’ O ’ 87 ’ 92 68, BS ’ ’ 68 ’ 55, MS ’ ouncil Gift 58 ’ Legacy C Deceased BSP DEVELOPMENT O * $1,000-$1,999 Stanton G. Ades, BSP $10,000-$24,999 Katherine Pedro Beardsley Robert S. Beardsley J. Boyle, PharmD Cynthia $2,000-$9,999 James L. Bresette, PharmD INDIVIDUAL DONORS David Stewart Associates $100,000 + Anonymous Ralph F. Shangraw , Jr. Marilyn Shangraw BSP ’58 Clayton L. Warrington, Elizabeth Warrington $25,000-$99,999 BSP ’65 Leon R. Catlett, Jerome Schwartz, BSP ’49 Mitzie Holen Schwartz, BS ’49 Gary L. Haas Henderson, BSP Robert W. Patrick E. Burke, BSP The Lovito Family The Lovito Family Phyllis Lovito Sr. Milton H. Miller, David R. Savello, PhD Alan Cheung John Autian, PhD Yale H. Caplan, PhD H. Caplan, Yale Conrad Peter Dorn , Jr., PhD Peter Dorn , Jr., Conrad Neil B. Leikach, BSP R. Gary Hollenbeck Anonymous Arnold E. Clayman, BSP John H. Balch, BSP David A. Knapp Deanne E. Knapp DeAnna D. Leikach, BSP Suzanne J. Caplan, BS Suzanne J. Caplan, Harold Chappelear, DSC Harold Chappelear, Ellen H. Yankellow, PharmD Ellen H. Yankellow, SSOCIATES A continued on page 26 lthough we are a public institution, private giving plays a critical role at strategic points in the a critical role at strategic private giving plays are a public institution, lthough we A exceptional education helps to fund an cycles. Private support and research School’s education discoveries that come developments and of exciting new students and the promise for deserving quality of our Doctor of as one of the top 10 in the nation for the from a School ranked contributions help to fuel the Report). Generous (U.S.News & World Pharmacy education a stronger School of that will ultimately change lives and ensure changes in health care the future. Pharmacy now and into UND F TEWART S

the mid 1980s, the School estab- the mid 1980s, the AVID NNUAL A faculty, students, alumni, year, Every and community members renew their support of the School of Pharmacy by Their investing in the Annual Fund. hundreds of gifts form a pool of unrestricted funds that may be wherever need applied strategically, and opportunity are greatest. The plays a vital role in Annual Fund ensuring the strength of all School of Pharmacy programs, providing for student scholarships and internships, faculty research projects, capital projects and improvements, acquisition of new technologies, and community In the lished its premier giving society, David Stewart Associates (DSA). America’s first professor of pharmacy, David Stewart, was a founder of the Maryland School of Pharmacy and its Through annual gifts and first chair. pledges of $1,000 or more, this core leadership of donors has created a solid base of private support for the School’s efforts to advance pharma- ceutical education and scholarship. join this prestigious group of alumni To and friends, or for information on giving to the School, please contact Alison Davitt. D 26 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 29 BSP ’82 , SP ’84 B BSP ’59 BSP ’56 BSP ’42 BSP ’54 , SP ’77 MS ’76, BSP ’72 BSP ’71 BSP ’81 BSP ’89 PharmD ’01 , , , PharmD ’94 , , , BSP ’91 PharmD ’98 BSP ’79 BSP ’79 B BSP ’61 , , , PharmD ’00 , BSP ’73 , , , , , , BSP ’63 BSP ’51 , PharmD ’01 BSP ’88 BSP ’51 BSP ’80 , PharmD ’98 BSP ’62 BSP ’81 , , BSP ’68 , BSP ’70 PharmD ’97 PharmD ’97 PharmD ’97 , , BSP ’88 , BSP ’87 BSP ’71 , , PharmD ’97 BSP ’62 , , , , , BSP ’73 PharmD ’99 , SP ’60 BSP ’78 BSP ’74 , PharmD ’96, BSP ’61 BSP ’83 PharmD ’99 harmD ’88 BSP ’89 , , , , , BSP ’83 , PharmD ’01 , , , , , B P , , PharmD ’98 PhD ’97, BSP ’89 , BSP ’76 , , , PharmD ’00 , BSP ’70 BSP ’78 BSP ’91 , BSP ’94 , , , BSP ’61 , , ichael Soscia ina H. Spiller Marshall R. Shure Marshall R. Gisele M. Sidbury uzanne Kieffer Simala uzanne Kieffer arry A. Snyder udith Wenzel Smith udith Wenzel Lane P. Zangwill James P. Tristani Irvin Yospa Sandra S. Werking James P. Struntz, Sr. Michael J. Steinberg J Brendon M. Williams Martin L. Yankellow Molrat Sripinyo Gregory J. Sophocleus Jae Hyung Wu Brett L. Steckman Frederic M. Weiss Frederic James B. Walter, Jr. James B. Walter, Kenneth C. Ullman Hal J. Weinstock Andrea B. Weiss Donna May Zarzuela Rudolph F. Winternitz Kathleen Edwards Truelove Rodney H. Taylor Ernest D. Testerman N Wayne D. VanWie Wayne Rebecca J. Waite S Eric R. Steele Jay A. Wenig Robert J. Weinberg H. Albert Svrjcek, Jr. Warren Eldred Weaver Warren Stephen M. Wienner Phillip P. Weiner Richard A. Wankel Nadine Renee Taylor Paul T. Tran Paul T. Ronald J. Spector Donna E. VanWie Norman R. Yockelson Frances Stichel Frances Alan R. Stoff Kathleen A. Sussman Anthony J. Sniadowski Francis John Tinney PhD ’66 Francis M. Tohnya Tanyifor Ronald E. Sweeney Nancy Lee Taylor Noel E. Wilkin Vicki S. Williams L Craig K. Svensson Craig Eric J. Yospa Bay-Mao B. Wu Helene L. Winters Barbara Dorsch Wirth Joann N. Wehnert James A. Spahn, Jr. Jenny Soscia M Shawn A. Sniadowski John C. Smith Huseyin C. Tunc , PharmD ’02 PharmD ’02 , , BSP ’68 PharmD ’00 , , BSP ’95 BSP ’80 BSP ’52 PharmD ’87 SP ’85 BSP ’77 BSP ’82 BSP ’95 , , , , BSP ’77 , , B , PharmD ’03 PharmD ’00 BSP ’51 , BSP ’69 BSP ’66 , , , , SP ’62 , BSP ’59 PharmD ’00, BSP ’89 , BSP ’86 SP ’81 BSP ’54 BSP ’76 BSP ’74 PhD ’82, BSP ’71 B , , BSP ’79 , , BSP ’56 PharmD ’97 BSP ’50 BSP ’86 , , BSP ’63 MS ’85, BSP ’81 PharmD ’01 B BSP ’63 , PharmD ’99 , , BSP ’52 , BSP ’50 PharmD ’00 PharmD ’00 , , , PharmD ’03 , , BSP ’78 , , , BSP ’56 , BSP ’80 , , BSP ’74 , PhD ’81, MS ’75, BSP ’76 , , BSP ’79 , , , BSP ’55 , BSP ’70 , BSP ’41 , , , BSP ’68 , PhD ’00 alter P. Mackay anaa S. Malaty obert J. Martin , Jr. BSP ’74 obert J. Martin , Jr. Frederick J. Mack Frederick rank D. Mackowiak oseph Marrocco Budne C. Reinke David M. Rombro James B. Ortt Howard R. Schiff Angela Marcia Parker Ann G. Mantelmacher Donna Y. Miller Donna Y. Anthony J. Petralia, Sr. Irvin Noveck Marcelus Porterfield Robert K. Moler Marvin Stanley Platt W John M. Motsko, Jr. Philip M. Perry Karen H. Nishi Lois A. Reynolds Mark Mallach Brian S. Robinette Edward R. Majchrzak, Sr. Ajaykumar M. Sharma Paul A. Pumpian Bonnie Darlene Purdy Dana S. Corn Mark J. Schocken Kristen K. Mack Daniel F. Mackley Cathie L. Schumaker Cathie F Khadijeh Rostamifard-Ahary Howard L. Robinson, Jr. Constanta Elena Samborschi Constanta Jodie A. Nguyen Lisa M. Matson, BSP ’88 Lisa M. Matson, BSP ’88 PHD ’85 Antonia Mattia, BSP ’88, PharmD ’04 John P. McArtor, PhD ’83 Madeline McCarren, BSP ’88 Maria Maggenti McCarthy, McDougall, BSP ’76 Margaret V. Mark P. McDougall, BSP ’85 BSP ’58 Harry Joseph McKenny, David A. McLucas, PharmD ’00 Lori Ann Mears, BSP ’82 Atul M. Mehta R Arnold Neuburger Herbert Plotkin Lawrence L. Martin Keith S. Pozanek Gary H. Magnus Robert H. Schumaker David Pearlman Craig F. Schaefer Craig Daniel S. Shaner Hanumantharao V. Ramachandruni Hanumantharao V. Carolyn Petralia Carolyn J Rebecca L. Marshall Thomas S. Shelor L. Joe Rolf H James R. Salmons Charlene S. Sampson * BSP ’54 , PharmD ’00 BSP ’59 BSP ’83 , , , BSP ’50 BSP ’56 SP ’93 BSP ’60 PhD ’96 , BSP ’63 BSP ’73 PharmD ’87 BSP ’84 , PharmD ’98 BSP ’83 , BSP ’84 PharmD ’00 SP ’76 BSP ’75 B , BSP ’51 BSP ’63 , , , BSP ’57 , , , , SP ’83 , BSP ’71 BSP ’69 , , , PharmD ’97 , PharmD ’96 B PharmD ’00 SP ’85 MS ’75, BSP ’71 , BSP ’84 PharmD ’95 , , SP ’62 , PharmD ’03 BSP ’60 BSP ’56 B , , , BSP ’83 BSP ’69 , BSP ’84 BSP ’77 B , , BSP ’72 , , , , PharmD ’99 , , BSP ’63 B , BSP ’80 , BSP ’83 BSP ’73 , BSP ’69 PharmD ’02 , , BSP ’92 , , , BSP ’73 , , BSP ’73 , , BSP ’74 BSP ’75 BSP ’90 PharmD ’80, BSP ’75 BSP ’85 , BSP ’79 BSP ’88 , , , , , BSP ’94 , , , , BSP ’85 PharmD ’04 , PharmD ’90, BSP ’88 , , BSP ’93 BSP ’87 , , , Lee J. Grier ary Therese Gyi eorge E. Groleau im H. Heimberger athryn L. Hatch ouis Gubinsky George J. Grimes, Jr. George J. Grimes, Jonathan N. Latham Stanley A. Klatsky Jung Eun Lee Mari E. Kim Lisa C. LeGette Thomas H. Keller, Jr. Thomas H. Keller, Robert J. Kreymer Paula P. Jandorf Kathrin C. Kucharski Lisa M. Johnson Patricia C. Ledford Michael E. Jones Timothy P. Lewis K Henry D. Leikach Janet M. Jones Laura Y. Kim Laura Y. Peggy A. Leary K Charles L. Jarvis, Sr. Anthony A. Guerra Charise S. Kasser Tali M. Johnson Tali Aaron C. Kadish Thomas J. Hayman Edward G. Kern Julie E. Limric, BSP ’69 Jr. William Irving Lottier, David A. Lewis Susan A. Katz Yacoub Suhail Habib Suhail Yacoub Suzanne Klies John J. Imwold, Jr. Treacy Krisztinicz Treacy Ronald H. Kronsberg Raymond T. Jackson Raymond T. Richard A. Hodges Kaysha R. Lancaster I. William Grossman Calvin Y. Lee Y. Calvin Felix A. Khin-Maung-Gyi Felix Jodi E. Lare Gregory P. Honshul Barry D. Hecht Leonard Horwits Cindy Q. Jiang Donald Raymond Helinski Ronald M. Hopkins Mark H. Lapouraille Pamela M. Lappen William B. Jackson, Jr. Cherokee L. Layson-Wolf Bruce H. Krug Suneel Kudaravalli G James M. Kellner Victoria G. Hale Christopher G. Kruft L Martin Jagers M Charles E. Leary Stephen L. Hilbert PharmD ’96 PharmD ’96 , BSP ’65 PharmD ’01 BSP ’69 , BSP ’85 , , , BSP ’82 PharmD ’00 BSP ’95 BSP ’78 PharmD ’05, BSP ’76 PharmD ’88 , , , , , BSP ’79 BSP ’57 harmD ’78, BSP ’76 harmD ’78, , BSP ’58 , , BSP ’76 BSP ’67 PharmD ’93 BSP ’79 PharmD ’86, BSP ’84 PharmD ’86, BSP ’94 . P MS ’91 BSP ’74 BSP ’70 BSP ’76 BSP ’79 , , , , BSP ’92 BSP ’83 PharmD ’02, BSP ’77 BSP ’80 PhD ’93, MS ’88 , BSP ’71 , , , BSP ’53 BSP ’75 , BSP ’72 , BSP ’79 , , , BSP ’68 BSP ’81 , , , , , PharmD ’03 , BSP ’86 , BSP ’63 , BSP ’92 , BSP ’63 , BSP ’73 PharmD ’03, BSP ’75 PhD ’67, MS ’64, BSP ’61 , PharmD ’93, BSP ’91 , BSP ’92 , , , PhD ’82, BSP ’77 , astro , , BSP ’47 , PharmD ’92 PharmD ’00 , ’81 BSP ’93 , BSP ’87 , BSP ’76 BSP ’79 , BSP ’76 , PharmD ’98, BSP ’83 , , BSP ’53 , , PharmD ’98 , , , , S , hD ’75, MS ’73 , vans ox abiano P erguson ohen M , owden , ouch Fabiano ader, II ader, . Chung Thomas Dolan Kevin Callahan o . arolyn B. Claudy . velyn R. Farinas red Choy ran Favin-Weiskopf erry L. Davis Century Club Century $100-$249 continued Beatriz N. Caceres-Gentile Linda G. Clary Yuet Lan M. Choy Yuet Henry H. Choi Phyllis Freiman Phyllis Freiman Irvin Friedman Rebecca J. De C Thomas P. E Donald B. Elliott, Jr Alisa M. Gilliard C Steven S. C Jami S. Earnest F David A. Custer Stephen S. Friedman Jack H. Freedman David R. C Mary J. Eckert Jean M. Dinwiddie Andrew Glorioso Ramakrishn R. Dandu E Monica A. Carter Lily Chua Eng Brian J. Gilligan Arnold F. Grabush Dana C. C F Kathleen Gondek Stewart Wesley Carter Stewart Wesley Robert Bruce Gerstein W Elliot S. Gottlieb Marilyn A. C Jennifer K. Grier Roselynn C. Ezeocha Danny R. Carter Geoffrey N. Christ Vincent L. F Paul Freiman Ann O. Dukes T Sallie W. Carr Carr Sallie W. Jennifer L. Carroll H A Louis Diamond James E. Dipaula Sharon M. Green John F. F Leslie D. Frank Jeanne B. Elliott Kathleen D. Flannery Dennis E. F Lena Y. Choe Lena Y. Joanne T Harry G. DeSantis William T. Foley, Jr. Foley, William T. Margarita A. Gambetta William G. Davies Carla Ann Gill Carla Marvin I. Gammerman John E. Gavlinski Karim Anton Calis Karim Anton www.umaryland.edu/ $50,000 Pharmacy Student Scholarships For additional information about mem- additional For . ouncil and estate planning, please contact Michele ouncil and estate planning, please contact $8,000 Student Organizations Support or by providing a copy of the relevant document in which the or by providing a copy ) OUNCIL echnology Educational T and Equipment $10,000 C FISCAL YEAR 2005 ANNUAL FUND ALLOCATION

Anyone who has made such a gift is eligible for membership by providing such a gift is eligible for membership Anyone who has made $9,000 Alumni Association and Alumni Publications

Faculty Faculty Development $10,000 eaningful contribution to the School. eaningful contribution EGACY wing. our financial circumstances, an annual gift is an opportunity to make a make to opportunity an annual gift is an circumstances, our financial plannedgiving School is named as a beneficiary L of the In Council efforts to recognize donors, the Legacy our continued donors who Baltimore was established to thank University of Maryland, through their contributions to the School of Pharmacy have made generous serves as spokesperson for (BSP ’58), L. Warrington estate plans. Clayton of the School. the council on behalf gift to the Office of Development ( documentation of the bership in the Legacy C E service programs that advanceRegardless the mission. academic School’s of y m 28 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 31 60% 50% 50% 50% 39% 36% 34% 33% 33% 32% 1942 1941 1945 1947 1963 1971 1956 1973 1970 1958 alumni giving op 10 Participating Classes T PharmD ’03 , BSP ’44 BSP ’76 SP ’81 BSP ’82 , , BSP ’88 B BSP ’66 , BSP ’89 , SP ’81 , PharmD ’77, , BSP ’87 PhD ’63, MS ’53, , MS ’60 , B , BSP ’82 , BS ’49 , , BSP ’61 , , , BSP ’69 MS ’59 BSP ’83 BSP ’83 BSP ’53 PharmD ’95 PharmD ’95 , MS ’53 BSP ’62 BSP ’72 BSP ’62 BSP ’40 PharmD ’03 PharmD ’03 BSP ’88 PharmD ’03 , SP ’70 , PharmD ’02 , BSP ’53 , BSP ’69 , BSP ’77 BSP ’81 BSP ’84 , , , , , , , , BSP ’86 , , , B , PharmD ’04 , BSP ’66 PhD ’01, PharmD ’97 PharmD ’91 , BSP ’56 BSP ’62 , BSP ’85 PHG ’31 BSP ’63 , , PharmD ’85 , , , , , BSP ’63 , PhD ’02, MS ’93 , , BSP ’78 , , BSP ’94 BSP ’83 BSP ’50 , , BSP ’55 , , , PharmD ’02 , PhD ’55, BSP ’53, MS ’52 PhD ’55, BSP ’53, MS ’52 , , BSP ’51 BSP ’75 ancy N. Kang athleen S. Kastama Sandra Seipp Johnson Sandra Seipp homas E. Johnson, Jr. homas E. Johnson, Aki Kanaganayaga Singam Albert G. Leatherman, Jr. Rebecca J. Lewis Melvin Levy Stonewall C. King, Jr. Linda R. King Lucy A. King Kelvin R. Levitt Albert W. Kossler Albert W. James L. Kirby Stephen B. Kistler Amelita P. Koh Bonnie Levin Linda Craig Klein Linda Craig Carl Kaiser Carl Donald Levy Christine J. Lafferman Charles John Kokoski Karen E. Koch Henry M. Levi Sung K. Kim Philip R. Karn, Sr. James L. Kessell Joseph T. Lundquist, IV Joseph T. Michael Alan Kesselman David L. Lowery Seymour L. London Marvin S. Kushnick Ronald L. Lindenbaum James G. Konrad Cheryl L. Lanier Stephen L. Lauer John T. Jordan, Jr. Jordan, John T. K Nhat H. Le William Knebel Tara A. Koontz Tara E. Koro Carol Frank Paul Kratz Frank Kelli Jubb Theresa K. F. Justice Frank T. Kasik, Jr. T. Frank Robert Lee Kestler Ronald R. Kessler Elmer Klavens Rozina Khanna Herbert Kwash Michael P. Long Ramon B. Juta Lauretta A. Kerr Susan Y. King Susan Y. Lana Konigsberg Kim H. Lam-Sun Thomas P. LaMartina T Jonathan M. Lipnick Richard S. Lipov Nathan H. Jones Melvin Lessing Barbara J. Kessler Jane M. LeGoff-Mitchell N PharmD ’02, , BSP ’55 , BSP ’43 BSP ’78 , BSP ’69 , BSP ’89 BSP ’49 , BSP ’73 , , PharmD ’99 , MS ’79 BSP ’83 BSP ’57 BSP ’38 PhD ’95, MS ’90 PhD ’02, PharmD ’98 , BSP ’41 PharmD ’93 BSP ’71 BSP ’81 , , BSP ’75 , BSP ’60 , BSP ’75 , harmD ’00 BSP ’55 , , , , , , PharmD ’02 BSP ’78 PharmD ’02, BSP ’86 , BSP ’90 , , MS ’33, PHG ’29 P BSP ’77 BSP ’81 BSP ’68 , , BSP ’60 , BSP ’91 BSP ’83 PharmD ’97 PharmD ’97 BSP ’90 , BSP ’60 , PHG ’33 , , , , , PhD ’97, BSP ’91 BSP ’50 , BSP ’87 , BSP ’90 , , SP ’79 PhD ’94 , PharmD ’04 PharmD ’96, BSP ’56 PharmD ’96, , BSP ’55 BSP ’80 PhD ’99 , , , PharmD ’94 , SP ’92 , , BSP ’83 BSP ’92 , BSP ’75 , B BSP ’93 , , , , , , , B , BSP ’93 , , BSP ’79 , BSP ’81 usan P. Flax aith A. Fisk ennifer L. Evans Michael J. Evanko, Jr. Michael J. Evanko, S Jerome L. Fine Leslye K. Fitterman Pavan K Heda Emanuel G. Freeman MaryJo Rankin Fisher Philip E. Fisher Doreen M. Heppert Trang H. Huynh Trang Margie Mae Goldberg-Okun Gerald J. Heilman April L. Hudson Martin D. Grebow Karen M. Fisher Abraham E. Glaser Lionel H. Jacobs James M. Galeotti F Scott W. Fisher Scott W. James J. Hanyok Michael P. Hiotis Thomas C. Goolsby Jane S. Hulko Kim P. Fisher Brian J. Goetz Robert R. Imbierowicz, Sr. Jon T. Holland Jon T. Leonard Jarkowski, Jr. Alice I. Harris Sharon Ann Hartman Dina S. Furrow Jill R. Fetter Frederick Robert Haase Frederick Al Hayes Margaret Hayes Heber Lisa V. Marta Hoffman Donald C. Grove Theresa L. Gibson Mary Louise P. Gierula Kara J. Heney Howard J. Gampel J. William Grimm Thurmon J. Gauldin Timothy C. Funk Fortin S. Georges Fortin Raman M. Iyer Herman Glassband Sam H. Haidar Gary Flax Herbert Gendason Donald J. Glenn Aaron Grebow Gilbert Hillman Harry B. Gendason J Helen A. Friel Helen A. Friel Jr. David R. Fulton, Michael C. Hawk Rajdeep K. Gill Huijeong A. Hahm Nigel Roger Isaacs Ronald Goldner BSP ’90 , BSP ’77 , BSP ’90 PharmD ’03 PharmD ’00 BSP ’78 BSP ’82 PharmD ’96 , , , , PharmD ’97 PharmD ’97 , , PharmD ’02 BSP ’86 PharmD ’99 BSP ’61 , SP ’83 BSP ’70 PharmD ’98 BSP ’75 BSP ’72 BSP ’43 PharmD ’98 SP ’71 , BSP ’69 PharmD ’97, BSP ’78 , , PharmD ’99 , BSP ’50 PharmD ’97 , , , , , BSP ’95 PharmD ’96, BSP ’92 BSP ’70 BSP ’53 , B BSP ’66 PharmD ’98, BSP ’71 BSP ’75 , BSP ’77 PharmD ’01 , BSP ’81 BSP ’93 , PharmD ’00 B , , BSP ’73 BSP ’59 PharmD ’98, BSP ’77 , , , , , BSP ’51 , , BSP ’56 , , , , PharmD ’97 BSP ’53 , , , BSP ’55 , , BSP ’92 , , , , , BSP ’90 SP ’86 BSP ’50 , BSP ’74 , BSP ’55 BSP ’80 , , , BSP ’77 B , , BSP ’85 PhD ’95 , , BSP ’74 PharmD ’98 , , , , ayle R. Caldwell K. Cheung arina Y. Chang arina Y. Rusty L. Butler Rusty L. Butler G p K. Judy Choi Nancy Croft Nancy Croft C. Richard Crooks Lisa M. Chester Barbara S. Chong Ana Isabel Almeida-Chiat Thomas P. Cargiulo Howard Crystal Nabila A. Ebrahim Irwin B. Epstein Marian L. Cascio Paul S. Chinnaraj Kimberly A. Couch Patrick L. Cunningham Paul J. Crist I Leslie G. Epstein Michael J. Cohen Terry P. Crovo Terry Hope S. DeCederfelt Ruyu Chang Liliane T. Elgamil Liliane T. Amy R. Corbett Matthew R. Esslinger Christie A Dunne Shivaun A. Celano Francis S. Eng Francis Barbara B. Doegen Susan Cohen-Pessah Robert M. Caplan Leroy K. Dunkley Christine J. Drew Norman Du Bois Jin Ah Choi Noel E. Durm Elizabeth A. Cicchetti Mary A. Card Richard E. Davis Jacklyn W. Collins Collins Jacklyn W. Susan C. Combs H. Cooksey Traci James E. Crouse M Jennifer A. Crampton Jennifer A. Crampton John J. Creamer Francine D. Danon Francine Nancy A. Edgeworth James P. Cragg, Jr. James P. Cragg, Michelle Dillahunt Dolores S. Dixon George T. Dooley George T. Malinda J. Darber Vincent R. DiPaula Lucille Cohen Carter Carter Lucille Cohen Paul M. Carter Deborah J. Ehart Kathryn M. DeMarco Hope B. Coleman Shirley W. Dickson Shirley W. Terri F. Clayman Terri Neil E. Esterson Donya M. Dabbah Randy S. Chiat BSP ’78 , SP ’81 BSP ’85 BSP ’89 PharmD ’79, BSP ’79 BSP ’58 , BSP ’70 , B PharmD ’00 , , PharmD ’97 , BSP ’55 , , , , BSP ’79 BSP ’55 , BSP ’57 PhD ’85 PharmD ’98 , BSP ’63 BSP ’84 , MS ’76, BSP ’73 PharmD ’03 PharmD ’01 , SP ’52 , , PhD ’53 MS ’63 MS ’52 PharmD ’80 , BSP ’95 , , , BSP ’81 , BSP ’72 BSP ’63 PharmD ’03 BSP ’83 BSP ’79 SP ’74 , MS ’74 , B BSP ’78 , BSP ’69 BSP ’91 BSP ’73 , BSP ’73 , BSP ’56 , , , , , , BSP ’63 BSP ’93 , BSP ’78 , , BSP ’90 , , , , BSP ’88 B , BSP ’66 PharmD ’88, BSP ’82 , , , , BSP ’83 , , PharmD ’93 , BSP ’78 , BSP ’94 , , , , BSP ’88 PharmD ’02 PharmD ’02 PharmD ’00 , , , BSP ’77 ontributors obert P. Zepp obert T. Adkins obert T. anet M. Abramowitz Vera Zejmis Vera C Up to $99 Gabriel A. Abiola Caroline T. Bader T. Caroline R Virna Ignacio Almuete Barbara Miller Blue Arthur Allen Lilian T. Alade Lilian T. Richard C. Benchoff, II Eileen Bloom Mary M. Ziomek Marlene I. Anarah Lawrence Aiken Wendy S. Burch Wendy Sydney L. Burgee, Jr. Rebecca J. Brenner Elaine L. Brogan Marianne Bayley Stephen P. Boykin Curtis A. Bowen Lisa L. Akman Deborah J. Bleakney Barry L. Bloom Mahiyar Arjomand Kimberly Dorsey Bronow Olita Brown Roberta L. Brown Nazeer N. Ahmed Gerald E. Beachy Barry A. Bookoff Nathan H. Abrahams Michael J. Appel Vahram Bedrossian Vahram Anand R. Baichwal William H. Batt Debra G. Bryan R Patricia A. Barditch-Crovo Michael J. Barton Diana M. Angleberger Susan Yun Ahn Susan Yun Susan K. Braun Ingrid R. Baramki Steven M. Beres Theophilus E. Awuah A. Edwin Balcerzak Nicolette P. Ballas Charles R. Bonapace Edward A. Bell Marian Butler Renan A. Bonnel Gary J. Aziz Dennis M. Ackerman Martha L. Adams Alan A. Abramowitz J Alvin G. Antwarg Michael T. Benson Michael T. Ali Anwar Amir Katherine P. Benderev Andrew Bartilucci HAIRS C

The Shangraw Chair is one of only In 2005, the Ralph Shangraw/

NDOWED Noxell Chair in Industrial Pharmacy and Pharmaceutics was completed with significant contributions from the Shangraw family and support from donors, faculty associates, and close friends of the late Ralph F. PhD. The chair is held by Shangraw, PhD. Larry Augsburger, two endowed chairs in U.S. colleges of pharmacy specifically supporting This generous industrial pharmacy. endowment ensures that the School can attract leaders in industrial phar- macy and continue to be recognized for its groundbreaking research and contributions to the field. E The School’s talented and nationally recognized faculty is not only a source of great pride, but also a cornerstone for our tradition of excellence. Endowed chairs serve to recognize faculty members of distinc- tion, foster academic excellence, and provide resources to strengthen research and teaching programs. Larry Augsburger, PhD Larry Augsburger, 30 SCHOOL OF PHARMACY FY05 ANNUAL REPORT 33

ships n • g io i t v a i l n

e g

r

•

• d

focus

o

t

n

r

o

o

r p

p s

u s • The Jerome and Mitzie Holen ELLOWSHIPS F thrives on innovation The School of the to keep it ahead and research edge and on the cutting competition a fellow- of the profession. Funding investment ship provides a long-term by nurturing in the School’s future or post- talented young scientists Since most PharmD clinicians. to a specific fellowships are directed families use area of training, many a personal this vehicle to advance interest. in Schwartz Graduate Fellowship Pharmaceutical Sciences was estab- lished to spur research related to understanding Alzheimer’s disease and related cognitive diseases to advance the diagnosis and treatment of Alzheimer’s disease. harmD ’04 P , BSP ’94 , SP ’42 PharmD ’01 PharmD ’01 harmD ’86, BSP ’75 , B BSP ’84 PharmD ’04 PharmD ’04 BSP ’78 , P , , , PharmD ’96, BSP ’90 PharmD ’96, BSP ’49 , BSP ’61 BSP ’77 BSP ’91 , , BSP ’91 , BSP ’74 BSP ’57 , , BSP ’92 BSP ’70 , , BSP ’63 , PharmD ’89 , PharmD ’98 , BSP ’95 [email protected] BSP ’93 , , , PharmD ’99 , , PharmD ’86 , , PharmD ’02 , have made every effort to provide a Raymond Weber e . ugene C. Weinbach Godfrey U. Ukwuoma onathan M. Walton-Roberts so that we may correct our records. Disclaimer W complete and accurate listing of donors and gifts. If we have made an error or omission, please accept our sincere apologies and contact Alison Davitt at 410-706-4415 or Warren G. Zerwitz Warren E Thomas M. Watts Brenda K. Weller Berhane H. Wold Leroy D. Werley, Jr. Leroy D. Werley, Paul J. Weidle Linda S. Wojcik Regina A. Wells William V. Zappa William V. Mary R. Zell James Douglas Yeargain D Joan P. Williams Amy Zhang Reid A. Zimmer Thomas D. Wieland Benjamin D. Wade Wade Benjamin D. J Nina M. Weidle Sarah Mills Voytko Sarah Mills Denise Von Rinteln Denise Von Mark S. Wienecke Laura D. Weiss Mandi E. Unterman Donald R. Young Ellen H. Wang SP ’82 BSP ’76 BSP ’80 MS ’76 B BSP ’94 , , PharmD ’00 , PharmD ’01 , , BSP ’36, PHG ’34 PharmD ’00, BSP ’67 PharmD ’01, BSP ’94 , PharmD ’04 BSP ’93 , BSP ’50 SP ’89 PharmD ’87 , , PharmD ’00, BSP ’78 PharmD ’02 , SP ’59 BSP ’78 , , BSP ’93 , BSP ’75 , BSP ’52 , , BSP ’94 B BSP ’37 , BSP ’86 BSP ’87 BSP ’71 B , BSP ’65 , , PharmD ’03 , BSP ’50 , BSP ’92 BSP ’50 BSP ’84 PharmD ’00 BSP ’62 , , BSP ’81 , , BSP ’93 , , BSP ’51 BSP ’79 BSP ’55 , BSP ’52 BSP ’95 BSP ’93 , , BSP ’67 BSP ’84 , , , , BSP ’92 PhD ’02 , BSP ’86 , , , , , , , , , BSP ’43 , BSP ’52 , , PharmD ’95 PharmD ’97 BSP ’79 , BSP ’88 , , , BSP ’51 , , , oure BSP ’63 , ravers soukleris ran ownley an Tran erbert A. Sachs uncan J. Runyon, Jr. racy R. Travers ennifer L. Rowan Mary Joe Robl Joseph L. Spiccioli Charles H. Steg, Jr. Howard I. Simon Thu V Cheryl L. T Charles D. Taylor, Jr. Charles D. Taylor, Belinda A. Todjo Jeffrey A. Rosen Melissa Alex Souder Lisa M. Schultz Marc R. Summerfield Emily W. Shifrin Emily W. Michael J. Shoemaker Cindy Schechter Jenell K. Theige H. Tillman Cecelia Charles J. Schutz Mona L. T Christie E. Schmidt Sylvan Tompakov Hans J. Rosenbach Emily Royster D Kim-Chi T Philip Schenker Vincent S. Sansone Milton F. Toelle T Susan B. Shermock Susan S. Shern Brian Todd Sevier Brian Todd Jean O. Schwartz Vicki P. T Henry Schwartz Irwin L. Samson Alvin Simon Denise I. Seldon Charlotte E. Slagle Morton Smith Steven Brian Toth, III Steven Brian Toth, Robert F. Royce Lionel M. Shapiro Allan B. Shenker Barbara L. Sabatino Carol E. Stevenson Carol Kelly E. Tinelli Michelle Lee Stine Julie D. Suman Morris W. Steinberg Morris W. Keith S. Rotenberg Keith S. Rotenberg Rotenberg Rochelle R. Eric R. Schuetz David V. Scallio David V. H Ronald C. Telak Todd H. Stephens Todd Allen Spak Liza N. Takiya Hamet M. T Joseph M. Ruppel Kenneth B. Sumpter Stephen E. Sussman Steven M. Simko J harmD ’97 BSP ’87 SP ’80 BSP ’91 , P PharmD ’02 BSP ’75 B , BSP ’59 PharmD ’02 BSP ’38 BSP ’65 , , , PharmD ’04 , , BSP ’62 , , , SP ’95 , BSP ’93 BSP ’73 BSP ’93 BSP ’95 , PharmD ’98 , PharmD ’96 BSP ’56 B , PharmD ’02 BSP ’74 BSP ’56 , , BSP ’59 BSP ’54 BSP ’47 BSP ’77 , BSP ’66 , BSP ’77 , , , BSP ’74 , , PharmD ’00 , , , , , , SP ’79 PharmD ’04 BSP ’51 , BSP ’80 BSP ’82 , PharmD ’04 BSP ’89 PharmD ’85 BSP ’49 BSP ’59 BSP ’77 BSP ’65 PharmD ’04, BSP ’93 , , , , PharmD ’04 BSP ’71 B , BSP ’71 , BSP ’81 , BSP ’63 , , BSP ’75 BSP ’45 , , , BSP ’42 , , BSP ’72 , BSP ’53 , , , , , , , , BSP ’85 , BSP ’58 Resser , . Rhodes Poole . . Phebus . ichael F. McMahon ichael V. McSwiggin ichael V. ancy Best Mabie arolyn M. Reeder eter J. Manso rances A. Owings Contributors $99 Up to continued Denise Lupo Lutz Denise Lupo Leonard N. Patras Sharon K. Park Irving M. Pruce Joseph D. Ober William W Joseph Pariser Andrei E. Nabakowski Mihi Ja Park Carla B. Perrott Carla Megan S. Potter Bruce David Marquette Janet F. Moffett Frank Stanley Parrish Frank C Milton Reisch Melissa Faye Miller Melissa Faye David A. Perrott Elizabeth C. Manning Elizabeth C. P Marcella L. Purdy Gerald M. Rachanow Nneka C. Onwudiwe Yvonne K. Molotsi Yvonne Claude W. Nogay Claude W. Gilbert C. Ngan Charlene A. Peterson Harris L. Miller Michael J. Priester Albert Prostic Morton L. Pollack John J. Novak Emanuel Richman Albert T. Meyers Albert T. N Barry W Howard B. Meyer James W Robert M. Plummer Arnold Pazornik Sheldon B. Pelovitz Thomas L. Morgan Harry E. Macks William C. Richmond F Meyer Oxman Philip B. Miller Ann M. Myers Ellen M. Perez Cheryl J. Phillips Richard D. Plotkin Monica L. Pogue Heather A. Owens Dinaxi G. Rami Stacy Pass Joanna C. Peverill Kelly Y Stanley J. Merwitz Matthew E. McGovern John C. Newton Edward T. McCagh, Jr. McCagh, Edward T. Kathleen M. Phelan M Kathryn Elizabeth Martin Kathryn Elizabeth Martin M Pharmaceutical Sciences The Boyle Legacy for Advocacy Scholarship The Beardsley Scholar Leader Scholarship The Eugene J. Lovito Memorial Scholarship

and saw the principal doubled through Gregory Scholarship Funds: • • • The following Presidential Endowed Scholarships were established in • in The Jerome and Mitzie Holen Schwartz Graduate Fellowship In 2005, Board of Visitors member John Gregory (BSP ’76, DPS ’02) In 2005, Board of Visitors member John In the next few decades, the health care system will reach a critical In the next few decades, the health care

05 Maryland-based drug-delivery technology company that provides formu- Maryland-based drug-delivery technology CHOLARSHIPS FY juncture as the demand for pharmacists and the elderly population contin- juncture as the demand for pharmacists the School With the establishment of additional scholarships, ue to grow. to societal needs and continue of Pharmacy will be positioned to respond dynamic field of pharmacy. producing professionals who impact the in honor of UMB President David and his wife, Joan, pledged $1 million Ramsay’s support DM, DPhil. The gift acknowledges President Ramsay, formation of UPM Pharmaceuticals, of the School and his leadership in the a testing, and regulatory docu- lation, clinical trial manufacturing, analytical companies. The School is using the mentation services to pharmaceutical gift as a matching fund to leverage the creation of additional endowed scholarships. Donors can qualify for a match with a gift of $25,000, and can name the scholarship as they wish. S By to the School of Pharmacy. Scholarship endowments are essential to deserving students who providing financial assistance in perpetuity to pursue their academic dreams, might not otherwise have the resources the best and brightest students they enable the School to compete for alumni and With the support of dedicated nationally and internationally. students will be supported friends, many of the School’s most promising throughout their academic career. Joan and John Gregory 32 CORPORATE PARTNERS IN PHARMACY EDUCATION The Corporate Partners in Pharmacy Education Program is designed to consolidate the School’s corporate donors, focus their giving, and provide prominent recognition for their support. BOARD OF VISITORS Contributions to this program support a variety of events at the School, including Honors Convocation, Graduation Banquet, and Career Day, as well as scholarships. 34 Robert Adams, BS, MGA James A. Miller, PD The School of Pharmacy would like to thank and recognize the following Corporate Partners in Pharmaceutical Consultant President/COO Pharmacy Education for their continued commitment and support: Anchor Pharmacies, Inc. TITANIUM LEVEL CVS/pharmacy John H. Balch, RPh President Milton H. Miller, Sr. PLATINUM LEVEL Giant Food/Ahold PharmaCare Cumberland Coldwell Banker Commercial NRT Safeway, Inc. David Blake, PhD Martin B. Mintz, PD, FASCP President President/CEO DAB Consulting, LLC Northern Pharmacy & Medical Equipment CORPORATE DONORS Patrons Child & Family Services of Tennessee Family Pharmacy of Hampstead, Inc. Harold E. Chappelear, BSP, (Hon.) LLD Richard P. Penna, PharmD, Chair $100,000+ CFC-Nat ’l Capital Area George’s Creek Pharmacy, Inc. Vice Chairman Executive Vice President (Retired) Commonwealth Fund Eli Lilly and Company Greater York Family Dentistry UPM Pharmaceuticals, Inc. American Association of Colleges Susan G. Komen Breast Cancer Fund Exxon Mobil Foundation GRS, Inc. of Pharmacy Finksburg Pharmacy Harford Pharmacy, Inc. Alan Cheung, PharmD, MPH Benefactors Fundraisers Unlimited Hill’s Drug Store, Inc. Executive Vice President (Retired) Robert G. Pinco, JD $50,000-$99,999 Giant Food Inc and Subsidiary Companies Hunt Valley Pharmacy, Inc. Advancis Pharmaceutical Corp GlaxoSmithKline James Pharmacy and Home Health Care CellWorks Attorney Board for Orthotist/Prosthetist Cert. Hoffmann-La Roche, Inc. Jarrettsville Pharmacy, Inc. Buchanan Ingersoll, PC Giant Food Foundation, Inc. Johns Hopkins Health System Kenneth C. Ullman, MD, PC Paul T. Cuzmanes, RPh, JD Health Care for the Homeless Johnson & Johnson Klein’s Supermarkets, Inc. of Maryland Divisional Director Gordon Sato, PhD The Lazarus Foundation, Inc. The John J. Leidy Foundation Christine B. Lafferman, MD FDA Associates Professor and Director Emeritus Merck & Company Incorporated McDougall’s Pharmacy and Drug Center Linthicum Pharmacy W. Alton Jones Open Society Institute McKesson Information Solutions, Inc. Lyon’s Pharmacy Russell B. Fair, RPh Robert Wood Johnson Foundation Mylan Pharmaceuticals Inc Maryland Pharmacists Association Vice President, Pharmacy Operations David R. Savello, PhD Sisters Together NeighborCare Pharmacies Maryland Science Center Giant Food, Inc. Senior Vice President Pharmacare of Cumberland Maryland Charity Campaign Cardinal Health’s Pharmaceutical Associates Pharmacia & Upjohn Foundation McDaniel College $25,000-$49,999 Rite Aid Corporation Mt. Carmel Medical, Inc. John M. Gregory, RPh, (Hon.) DPS Technologies & Services Group American Association of Colleges Russo’s Rx Mt. Vernon Pharmacy Managing Partner of Pharmacy The Safeway Companies Novartis Pharmaceuticals Corporation SJ Investments Stephen C. Schimpff, MD Catlett Enterprises, Inc Shoppers Food & Pharmacy Park Avenue Pharmacy CEO (Retired) Anonymous Target Corporation The Pfizer Foundation, Inc. William M. Heller, PhD, (Hon.) DSc University of Maryland Medical Center National Cancer Center The Merck Company Foundation Plastic Surgery Services, Inc. Executive Director (Retired) PhRMA Foundation UPM Pharmaceuticals, Inc. Rexall Drugs, Inc. United States Pharmacopeia Alex Taylor, BSP Rite Aid Foundation Walgreens Senior Pharmacists Assoc. of Maryland Correct Rx Pharmacy Services, Inc. Wyeth Pharmaceuticals World Reach, Inc. SuperValu Robert W. Henderson, PD United Charity Campaign of Maryland President/CEO David R. Teckman Affiliates Contributors Verizon Foundation $10,000-$24,999 Up to $999 Watermont Pharmacy, Inc. Nutramax Laboratories, Inc. President/CEO CVS Corporation American Pharmacists Association Wyeth Consumer Healthcare Division Vivius, Inc. Gerontology Society of America The Annapolitan Shop, Inc. Donald M. Kirson, BSP Nutramax Laboratories, Inc. AstraZeneca President/CEO (Retired) George C. Voxakis, PharmD Aventis Pharmaceutials Products, Inc. Corporate Matching Gifts Kirson Medical Equipment Company President Sponsors B. I. L., Inc. t/a State Pharmacy AstraZeneca American Liberty Financial Services, Inc. $1,000-$9,999 Beward Pharmacy Aventis Pharmaceutials Products, Inc. Calvin Knowlton, PhD Ahold Financial Services BMC Pharmacy, Inc. t/a Ritchie Pharmacy Bristol-Myers Squibb Foundation Chief Executive Officer Clayton L. Warrington, BSP American Heart Association, Nat’l Bristol-Myers Squibb Foundation Bristol-Myers Squibb Pharmaceutical ExcelleRx Chairman (Retired) American Society of Consultant Broadway Pharmacy, Inc. Eli Lilly and Company Dugan/Farley Communications Pharmacists Builders Marketing Services, Inc. Eli Lilly and Company Foundation Associated Black Charities Caton Pharmacy Exxon Mobil Foundation Henri Manasse, PhD Associated Jewish Community Federation Chandler’s Drug and Medical Supply Inc. GlaxoSmithKline Executive Vice President Ellen H. Yankellow, PharmD Boonsboro Pharmacy, Inc. Cohen Family Fund Novartis Pharmaceuticals Corporation American Society of Health-System Pharmacists President/CEO Bristol-Myers Squibb Pharmaceutical The Drug Store Pharmacia & Upjohn Foundation Correct Rx Pharmacy Services, Inc. Burke Drugs, Inc. t/a Chestnut Pharmacy Eastern Savings Bank The Merck Company Foundation Gina McKnight-Smith, PharmD, MBA Cardinal Health Eli Lilly and Company Foundation The Pfizer Foundation, Inc. Clinical Coordinator-Maryland Catonsville Pharmacy, LLC Empire Professional Pharmacy Verizon Foundation Provider Synergies 20 N. Pine Street Baltimore, MD 21201-1180

Change Service Requested